NIH Institute Fit Guide: NIAID, NCI, NHLBI, NINDS, or NIGMS?
Choose the right NIH institute based on disease area, study design, and translational intent before proposal investment.
NIAID
- Infectious disease, immunology, allergy, and global health security priorities
- Strong fit for vaccines, diagnostics, antimicrobials, and pandemic preparedness
- Often overlaps with BARDA for translational and countermeasure programs
NCI
- Oncology-focused basic, translational, and clinical research programs
- Strong fit when cancer biology, therapeutics, or prevention science is central
- Reviewers expect rigorous study design tied to cancer-specific outcomes
NHLBI
- Cardiovascular, pulmonary, blood, and sleep disorder research
- Strong fit for device, therapeutic, and population-health programs in these domains
- Emphasis on mechanistic clarity and clinical relevance to heart/lung disease
NINDS
- Neurological and neurodegenerative disease research priorities
- Strong fit for brain-computer interfaces, neural therapeutics, and CNS diagnostics
- Reviewers expect strong rationale linking intervention to neurological endpoints
NIGMS
- Basic biomedical science and cross-cutting methodological research
- Strong fit for fundamental biology, computational methods, and training-linked programs
- Less disease-specific than institute-focused R01 pathways
Velawolf recommendation
When institute fit is ambiguous, run a parallel fit assessment across two institutes and align study aims to the institute with the strongest mission overlap and review culture match.